Patients Urge 1st Circ. To Revive Sanofi Drug Dispute
Patients with a life-threatening genetic disorder tried to restart their case against Sanofi subsidiary Genzyme in the First Circuit on Friday, arguing that a Massachusetts federal judge had been too hard...To view the full article, register now.
Already a subscriber? Click here to view full article